ESC Premium Access

Comparison of two anthracycline regimens for treatment of breast cancer and the incidence of cardiac injury

Congress Presentation

About the speaker

Doctor Nichanan Osataphan

Chiang Mai University, Chiang Mai (Thailand)
1 presentation
0 follower

5 more presentations in this session

Prospective screening and proposed treatment algorithm for immune checkpoint inhibitor induced myositis in neoadjuvant-treated rectal cancer patients: data from the phase II CHINOREC trial

Speaker: Doctor R. Zirnbauer (Vienna, AT)

Thumbnail

Cardioprotective role of statins in breast cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis

Speaker: Doctor S. Lingamsetty (Khammam, IN)

Thumbnail

Anthracycline-induced arterial toxicity: structural and inflammatory assessments in non-human primates and lymphoma patients using 18F-FDG positron emission tomography

Speaker: Doctor S. Rankin (Glasgow, GB)

Thumbnail

Validation of the HFA-ICOS risk assessment tool with real-world data from a prospective cohort of breast cancer patients in treatment with anthracyclines and trastuzumab

Speaker: Doctor E. Guerra (Tlalpan, MX) Doctor N. Espinola-Zavaleta (Mexico City, MX)

Thumbnail

Incidence, definitions and outcomes of anthracycline induced subclinical and clinical left ventricular dysfunction: a systematic review and meta-analysis

Speaker: Doctor N. Farooqui (Rochester, US)

Thumbnail

Access the full session

Cardiomyopathy in cancer patients: prevalence, risk assessment, imaging, and prevention

Speakers: Doctor N. Osataphan, Doctor R. Zirnbauer, Doctor S. Lingamsetty, Doctor S. Rankin, Doctor E. Guerra...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations